Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,528.8
41.2 (1.66%)

 

  • STI Straits Times Index
    2,528.8
    41.2 (1.66%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,343.1
    15.0 (1.13%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,484.3
    131.9 (0.56%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,772.2
    7.3 (0.26%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    19,389.4
    724.8 (3.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,545.6
    206.7 (4.76%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,154.6M
  • Value: 1,885.1M
  • Rise: 274
  • Fall: 88
  • Unch: 450

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Genting Sing0.665+0.050
Singtel2.570+0.050
ThaiBev0.610+0.015
Mapletree Log Tr1.600+0.060
Rex Intl0.090+0.001
ESR-REIT0.320+0.010
YZJ Shipbldg SGD0.850+0.020
NetLink NBN Tr0.885-0.015
Ascendas Reit2.780+0.110
Medtecs Intl0.074+0.003

World Indices

World Indices
Name Last Change
Nasdaq 7,502.4 -295.2
HSI 23,484.3 +131.9
HSCEI 9,504.9 +57.4
Jakarta 4,545.6 +206.7
Nikkei 225 19,389.4 +724.8
SSE Comp 2,772.2 +7.3
Shanghai A 2,905.2 +7.7
Shanghai B 218.9 -0.2
KOSPI 1,717.7 +31.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

APPLIED THERAPEUTICS INC APPLIED THERAPEUTICS
Updated on 27 Mar 2020 (End of trading day)
Last (USD): 30.440 Change: +0.010 High: 31.500 Remarks: -
Change (%): +0.03 Low: 27.910
Open 29.850 Yesterday's Close 30.43
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 103,305 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.75200 Trailing EPS (USD) e -2.07166 NAV (USD) b 1.4842
PE a - Trailing PE f - Price / NAV b 20.5094
Dividend (USD) d - Cash In Hand (USD) g 0.8580 Issued & Paid-up Shares c 21,969,300
Dividend Yield (%) d - Price / Cash In Hand g 35.478 Treasury Shares h -
Beta - 75 Daysi 1.332 R-Squared - 75 Days(%)i 25.53 Market Cap (M) 668.745
Beta - 500 Daysi 1.111 R-Squared - 500 Days (%)i 12.40 Enterprise Value (M) 631.930
Piotroski F Score 3 Exchange Code APLT Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 55.6
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Mar 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 May 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference APPLIED THERAPEUTICS INC NASDAQ 668.745 - - 20.5094 -
Industry Pharmaceuticals: Major NASDAQ 1,270.499 113.461 1786.655 2.0185 0.012
Local Peer SANOFI SPON ADR ECH REP 1/2 ORD EUR2 LEVEL II NASDAQ 106,426.364 20.887 33.956 1.6088 2.705
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 5,398.426 7.669 7.725 0.9973 3.769
Local Peer REATA PHARMACEUTICALS INC NASDAQ 4,984.117 - - 19.4041 -
Local Peer REPLIGEN CORP NASDAQ 4,820.374 290.089 225.135 4.5485 -
Local Peer FORTY SEVEN INC NASDAQ 4,553.150 - - 14.3214 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 3,059.307 4.490 - 2.1768 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 2,397.676 - - 8.3249 -
Local Peer ALLAKOS INC NASDAQ 2,335.062 - - 4.7104 -
Local Peer RA PHARMACEUTICALS INC NASDAQ 2,219.730 - - 8.4686 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 1,977.943 - - 57.7905 -
Local Peer KARUNA THERAPEUTICS INC NASDAQ 1,846.937 - - 4.7368 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 1,672.896 340.226 - 4.6601 -
Other Local Peers TURNING POINT THERAPEUTICS INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), ATHENEX INC (NASDAQ), PETIQ INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), 89BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), EVOLUS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), ARTARA THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), GENPREX INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), AKORN INC (NASDAQ), IMMUNIC INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), ASSERTIO THERAPEUTICS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), EYENOVIA INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), BAUDAX BIO INC (NASDAQ), MEDIWOUND LTD (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), ENTERA BIO LTD (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), MANNATECH INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), PROPHASE LABS INC (NASDAQ), NOVAN INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 324,692.866 21.226 21.476 5.4597 2.903
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 200,370.686 15.852 17.052 3.6120 2.125
Global Peer MERCK & CO INC NYSE 181,926.647 29.249 18.483 7.0223 2.836
Global Peer PFIZER INC NYSE 171,422.076 15.371 10.535 2.7156 4.602
Global Peer ELI LILLY AND COMPANY NYSE 128,348.366 39.712 27.674 49.2346 1.853
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 119,435.263 24.276 34.730 2.3147 2.189
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 111,458.693 51.808 82.990 8.4908 3.115
Global Peer ABBVIE INC NYSE 107,309.609 18.969 13.689 -13.1313 5.443
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 105,663.029 17.282 18.082 12.2134 2.004
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 91,410.104 18.922 15.482 5.7578 5.552
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), SINOPHARM (HKEx), INNOVENT BIO-B (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), CHINARES PHARMA (HKEx), CANSINOBIO-B (HKEx), JUNSHI BIO-B (HKEx), CMS (HKEx), HENLIUS-B (HKEx), TRAD CHI MED (HKEx), SSY GROUP (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINAGRANDPHARM (HKEx), INNOCARE-B (HKEx), ZYMEWORKS INC (NYSE), CKLIFE SCIENCES (HKEx), TONGRENTANGCM (HKEx), UNITED LAB (HKEx), CSTONE PHARMA-B (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), SHINEWAY PHARM (HKEx), IGBB (Bursa), Kimia Farma Tbk. (IDX), FUSEN PHARM (HKEx), HUA MEDICINE-B (HKEx), LANNETT CO INC (NYSE), DAWNRAYS PHARMA (HKEx), TOT BIOPHARM-B (HKEx), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), BIOMX INC (NYSE American), CH BIOTECH-20K (HKEx), CH BIOTECH-5K (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), ZHONGZHIPHARM (HKEx), PYC THERAPEUTICS LIMITED (ASX), CHARMACY PHAR (HKEx), NC HEALTHCARE (HKEx), PAK FAH YEOW (HKEx), NEW RAY MEDIC (HKEx), PHARMA (Bursa), IX Biopharma (SGX), KOTRA (Bursa), Phapros Tbk. (IDX), NEP INTERLONG (HKEx), Merck Tbk. (IDX), ONCOSIL MEDICAL LIMITED (ASX), WAI YUEN TONG (HKEx), PALLA PHARMA LTD (ASX), PURAPHARM (HKEx), Hyphens Pharma (SGX), SANAI HEALTH GP (HKEx), TBG DIAGNOSTICS LTD (ASX), NOVA (Bursa), AGEX THERAPEUTICS INC (NYSE American), IP (SET), JCT (SET), EXTRAWELL PHAR (HKEx), ANNOVIS BIO INC (NYSE American), INVION LTD (ASX), RECCE PHARMACEUTICALS LTD (ASX), BIOHLDG (Bursa), SINOLIFE UTD (HKEx), MEDLAB CLINICAL LIMITED (ASX), PHARMAXIS (ASX), RACE ONCOLOGY LTD (ASX), PASHUN INT'L (HKEx), ACRUX (ASX), NOXOPHARM LTD (ASX), EXOPHARM LTD (ASX), TALI DIGITAL LIMITED (ASX), IMMURON LIMITED (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), CRESO PHARMA LTD (ASX), FARMAFORCE LTD (ASX), CELLMID LIMITED (ASX), SUNZEN (Bursa), SUDA PHARMACEUTICALS LTD (ASX), Pharmesis Intl (SGX), FIJI KAVA LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+3.440
+12.74 %
10 Days -+2.610
+9.38 %
20 Days --11.110
-26.74 %
Medium Term Return 3 Months -+4.360
+16.72 %
6 Months -+20.515
+206.70 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 7.950 - 57.390 Change From 1 Year Low +22.490 % Change From 1 Year Low (%) +282.89
Change From 1 Year High -26.950 % Change From 1 Year High (%) -46.96
2 Years Range 7.950 - 57.390 Change From 2 Years Low +22.490 % Change From 2 Years Low (%) +282.89
Change From 2 Years High -26.950 % Change From 2 Years High (%) -46.96
5 Years Range 7.950 - 57.390 Change From 5 Years Low +22.490 % Change From 5 Years Low (%) +282.89
Change From 5 Years High -26.950 % Change From 5 Years High (%) -46.96
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
27 Mar 2020 29.850 31.500 27.910 30.440 103,305 -
26 Mar 2020 30.750 34.820 29.000 30.430 139,594 -
25 Mar 2020 29.590 31.945 27.550 30.020 86,971 -
24 Mar 2020 29.610 31.920 28.180 29.580 129,149 -
23 Mar 2020 27.340 29.560 24.330 27.990 147,426 -
20 Mar 2020 24.850 28.270 24.300 27.000 525,361 -
19 Mar 2020 20.780 26.597 20.780 25.190 147,006 -
18 Mar 2020 21.630 23.230 19.950 21.280 196,161 -
17 Mar 2020 20.270 23.920 18.460 23.200 266,159 -
16 Mar 2020 24.730 26.490 18.630 19.540 152,348 -
13 Mar 2020 28.310 31.420 25.095 27.830 144,356 -
12 Mar 2020 27.530 30.002 23.053 27.010 272,505 -
11 Mar 2020 33.110 33.440 29.200 29.590 226,598 -
10 Mar 2020 34.730 36.760 30.945 34.100 153,632 -
09 Mar 2020 37.910 40.000 34.040 34.280 287,262 -
06 Mar 2020 38.650 42.258 38.640 41.110 157,751 -
05 Mar 2020 43.400 44.200 39.665 40.400 91,150 -
04 Mar 2020 42.000 44.780 40.137 44.560 68,251 -
03 Mar 2020 41.740 42.590 40.030 41.590 112,418 -
02 Mar 2020 41.760 42.220 39.810 41.870 209,818 -
28 Feb 2020 40.710 41.770 38.015 41.550 158,397 -
27 Feb 2020 42.500 42.900 39.675 41.650 180,714 -
Summary
Current 2 Weeks
(16 Mar 2020 to 27 Mar 2020)
24.730 34.820 18.460 30.440 1,893,480 -
Previous 2 Weeks
(02 Mar 2020 to 13 Mar 2020)
41.760 42.220 18.460 27.830 1,723,741 -
4 Weeks from
(31 Jan 2020 to 28 Feb 2020)
55.110 55.850 18.460 41.550 4,186,553 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.